Browsing "Comunicações em Eventos - LIM/24" by Title

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 577  next >
Issue DateTitleAuthor(s)
20187-Ketocholesterol loaded-phosphatidylserine liposome induces cell death, autophagy, and growth inhibition of melanoma and breast adenocarcinoma.FAVERO, Giovani Marino; TORTELLI JR., Tharcisio Citrangulo; FERNANDES, Daniel; PRESTES, Ana Paula; KMETIUK, Louise N. B.; OTAKE, Andreia Hanada; ANDRADE, Luciana N. S.; FARIA, Daniele de Paula; CARNEIRO, Camila de Godoi; GARCEZ, Alexandre Teles, et al
2015(99m) technetium-Tocilizumab Fragments As Molecular Imaging Agent for Multiple MyelomaCAMACHO, Ximena; MACHADO, Camila; GARCIA, Maria Fernanda; FERNANDEZ, Marcelo; ALONSO, Omar; CERECETTO, Hugo; CHAMMAS, Roger; GAMBINI, Juan Pablo; CABRAL, Pablo; RIVA, Eloisa
2013A phase 3, randomized, open-label trial comparing trastuzumab emtansine and trastuzumab as adjuvant therapy for HER2-positive primary breast cancer with residual invasive tumor in the breast or axillary lymph nodes following preoperative therapy (KATHERINE)GEYER, C. E.; LOIBL, S.; MAMOUNAS, E. P.; UNTCH, M.; WOLMARK, N.; HUANG, C-S; MANO, M.; ZHENG, M.; SMITT, M.; MINCKWITZ, G. von
2014A Phase I Study of Imatinib, Dacarbazine, and Capecitabine in Advanced Endocrine CancersHALPERIN, Daniel M.; HOFF, Paulo; HOFF, Ana O.; PHAN, Alexandria; YAO, James C.
2013A phase II randomized study of lapatinib in combination with capecitabine, vinorelbine or gemcitabine as first or second line-therapy in patients with HER2 positive metastatic breast cancer progressing after taxane (LACOG 0801)GOMEZ, H.; NECIOSUP, S.; TOSELLO, C.; MANO, M.; BINES, J.; ISMAEL, G.; SANTI, P. X.; PINCZOWSKY, H.; NERON, Y.; FANELLI, M., et al
2014A phase II trial of metformin and fluorouracil (MetFU) for patients (pts) with metastatic colorectal cancer (mCRC) refractory to standard treatmentMIRANDA, Vanessa Costa; FARIA, Luiza Dib; BRAGHIROLI, Maria Ignez Freitas Melro; JACOBS, Monica; SABBAGA, Jorge; HOFF, Paulo Marcelo; RIECHELMANN, Rachel Pimenta
2015A phase III, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of pregabalin in the prevention and reduction of oxaliplatin-induced painful neuropathy (PreOx)ANDRADE, Daniel Ciampi de; TEIXEIRA, Manoel Jacobsen; GALHARDONI, Ricardo; FERREIRA, Karine A. S. L.; MALIENO, Paula Braz; SCISCI, Nathalia; RIECHELMANN, Rachel Pimenta; TEIXEIRA, William G. J.; SARAGIOTTO, Daniel Fernandes; SILVA, Valquiria Aparecida, et al
2012A quantitative sequencing based method for the monitoring of clonal expansionSTRAUSS, Bryan E.; ZANATTA, Daniela; AGUIAR, Rodrigo B. de
2012A randomized, open-label, phase II study of lapatinib/capecitabine, lapatinib/vinorelbine, or lapatinib/gemcitabine in patients with ErbB2-amplified metastatic breast cancer progressing after taxane treatment: Results of an interim analysis (GLICO-0801/EGF111792)GOMEZ, Henry Leonidas; NECIOSUP, Silvia P.; TOSELLO, Celia; XAVIER, Patricia; NASCIMENTO, Yeni Neron do; FANELLI, Marcelo; ISMAEL, Gustavo; BINES, Jose; SAMPAIO, Carlos; LERZO, Guillermo Luis, et al
2016A retrospective study of chemoradiotherapy (CRT) versus chemotherapy (CT) as adjuvant treatment for localized gastric cancer (LGC)GIRARDI, D. D. M.; PEREIRA, G. C.; NEGRAO, M.; LIMA, M. A.; FELIZOLA, M. M.; FOGACE, R. N.; CAPARELI, F. C.; SABBAGA, J.; HOFF, P. M.
2014Acromegaly Due to Ectopic Secretion of GHRH Mimicking a GH-Secreting Pituitary Adenoma: The Role of Imaging and GHRH AssaySANTANA, Nathalie Oliveira; JALLAD, Raquel S.; DUARTE, Felipe H. G.; RIECHELMANN, Rachel Simoes Pimenta; RAVEROT, Veronique; TROUILLAS, Jacqueline; RAVEROT, Gerald; BRONSTEIN, Marcello D.
2012Activated Wnt signaling pathway is not influenced by absence of galectin-3 in mice during tongue malignant transformationSOUZA, M. V. R.; CHAMMAS, R.; SANT'ANA, J. M. A.; LOYOLA, A. M.; CARDOSO, S. V.; FARIA, P. R.
2017Adjuvant carboplatin and paclitaxel chemotherapy followed by radiotherapy in high-risk endometrial cancer: A retrospective analysis.BONADIO, Renata Rodrigues da Cunha Colombo; AZEVEDO, Renata Gondim Meira Velame; HARADA, Guilherme; COSTA, Samantha Cabral Severino da; MIRANDA, Vanessa Costa; FREITAS, Daniela de; FILHO, Elias Abdo; FERREIRA, Patricia Alves de Oliveira; GABRIELLI, Flavia; ESTEVEZ-DIZ, Maria Del Pilar
2016Aflibercept plus FOLFIRI for 2nd line treatment of metastatic colorectal cancer (mCRC): Long-term safety observation from the global aflibercept safety and quality-of-life (QoL) program (ASQoP)RIECHELMANN, R.; SRIMUNINNIMIT, V.; KAVAN, P.; BARTOLOMEO, M. Di; MAIELLO, E.; CICIN, I.; KROENING, H.; GARCIA-ALFONSO, P.; CHAU, I.; FERNANDEZ-MARTOS, C., et al
2015An international, biomarker-directed, randomized, phase II trial of AZD1775 plus paclitaxel and carboplatin (P/C) for the treatment of women with platinum-sensitive, TP53-mutant ovarian cancer.OZA, Amit M.; WEBERPALS, Johanne Ingrid; PROVENCHER, Diane M.; GRISCHKE, Eva-Maria; HALL, Marcia; UYAR, Denise; ESTEVEZ-DIZ, Maria Del Pilar; MARME, Frederik; KUZMIN, Alexey; ROSENBERG, Per, et al
2013AN OPEN-LABEL, MULTICENTER, RANDOMIZED, PHASE II STUDY OF CISPLATIN AND PEMETREXED WITH OR WITHOUT CIXUTUMUMAB (IMC-A12) AS FIRST-LINE THERAPY IN PATIENTS WITH ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCERSCAGLIOTTI, Giorgio; CASTRO JR., Gilberto; KIYIK, Murat; RUBEN, Kowalyszyn; DEPPERMANN, Karl-Matthias; ARRIOLA, Edurne; BOSQUEE, Lionel; WILLEY, Richard G.; COSAERT, Jan; RECK, Martin
2021Analysis of Results of Hand-Sewn vs Mechanical Esophageal Anastomosis after Total Gastrectomy: A Systematic Review and Meta-analysis.CABRAL, Fernanda C.; EMILIO FILHO, Joao P.; TUSTUMI, Francisco; HENRIQUES, Alexandre C.; WAISBERG, Jaques; DIAS, Andre R.; FUHRO, Felipe E.
2019Anatomical topography of the tumor is related to prognostic survival in adenocarcinoma of esophagogastric junction?: Multivariable analysis.TAKEDA, Flavio Roberto; SALLUM, Rubens Antonio Aissar; RIBEIRO, Ulysses; CASTRIA, Tiago Bianchi de; TUSTUMI, Francisco; ROCHA, Julio Rafael Mariano; CECCONELLO, Ivan
2017Anti-LeY monoclonal antibody (mAb) hu3S193 as consolidation therapy for patients (pts) with relapsing platinum sensitive ovarian cancer (OC) after achieving a second complete response (2CR).SMALETZ, Oren; ISMAEL, Gustavo; ESTEVEZ-DIZ, Maria Del Pilar; NASCIMENTO, Ivana Lucia Oliveira; WIERMANN, Ana Luiza Gomes de Morais; CUNHA, Geraldo Felicio; AZEVEDO, Sergio J.; ALVES, Venancio A.; MORO, Ana M.; YEDA, Fernanda Perez, et al
2012Anti-tumor Effect of P19Arf and Interferon-beta Gene Transference to Mouse Melanoma and Mouse Lung Carcinoma Cells is Revealed by a Strong Bystander Activity and a Potential Immune ResponseRIBEIRO, A. H.; MEDRANO, R. F. V.; CATANI, J. P. P.; STRAUSS, B. E.